| Identification | Back Directory | [Name]
S-[(2S)-2,3-Bis[(1-oxohexadecyl)oxy]propyl]-L-cysteinyl-L-valyl-L-glutaminylglycyl-L-α-glutamyl-L-α-glutamyl-L-seryl-L-asparaginyl-L-α-aspartyl-L-lysine | [CAS]
1039381-80-0 | [Synonyms]
S-[(2S)-2,3-Bis[(1-oxohexadecyl)oxy]propyl]-L-cysteinyl-L-valyl-L-glutaminylglycyl-L-α-glutamyl-L-α-glutamyl-L-seryl-L-asparaginyl-L-α-aspartyl-L-lysine | [Molecular Formula]
C77H135N13O24S | [MOL File]
1039381-80-0.mol | [Molecular Weight]
1659.04 |
| Chemical Properties | Back Directory | [Boiling point ]
1746.9±65.0 °C(Predicted) | [density ]
1.217±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | [pka]
3.14±0.10(Predicted) | [Sequence]
{1,2-Dipalmitoyl-sn-glycerol}-Cys-Val-Gln-Gly-Glu-Glu-Ser-Asn-Asp-Lys |
| Hazard Information | Back Directory | [Uses]
CBLB 612 is an anti-radiation auxiliary agent and anti-tumor agent[1]. | [References]
[1] Cao Jinquan. Pharmaceutical composition. Patent. CN104027791.
[2] Cao J, et al. Pharmaceutical composition containing CBLB612 and used in anti-radiation auxiliary drug or anti-tumor auxiliary drug. China, CN104027791 A. 2014-09-10. |
|
|